Tilray Brands, Inc. (TLRY)
Automate Your Wheel Strategy on TLRY
With Tiblio's Option Bot, you can configure your own wheel strategy including TLRY - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol TLRY
- Rev/Share 10.5858
- Book/Share 19.5793
- PB 0.389
- Debt/Equity 0.2023
- CurrentRatio 2.8125
- ROIC -1.1239
- MktCap 787711362.0
- FreeCF/Share -0.8562
- PFCF -8.3376
- PE -0.291
- Debt/Assets 0.1523
- DivYield 0
- ROE -1.1412
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 5
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | TLRY | Canaccord Genuity | -- | Hold | -- | -- | Jan. 27, 2026 |
News
3 Canadian Marijuana Stocks Today's Stock Market That Could Soon Run
Published: February 04, 2026 by: MarijuanaStocks
Sentiment: Positive
The cannabis industry is in another pivotal time where consistent changes are being made. Laws and regulations have been passed across the country that have aided in the further development of industry. For most marijuana stock investors, this is the area where shareholders tend to focus. Investors know that a company is doing well, or is working towards a significant goal, which can all lead to profitability. There are different sectors and markets to pay attention to.
Read More
Tilray Brands Ignites Championship Sunday: Nationwide Tap Room Events, Big Game Day Deals, and Fan Experiences Announced
Published: February 03, 2026 by: GlobeNewsWire
Sentiment: Neutral
Gear up for game day, Sunday, February 8, 2026, with ultimate fan experiences, beer, wings, whiskey, and more at SweetWater Brewing Co., Montauk Brewing Co., Breckenridge Brewery, Blue Point Brewing Co., 10 Barrel Brewing Co., Hop Valley Brewing Co., Terrapin Beer Co., and Atwater Brewery Gear up for game day, Sunday, February 8, 2026, with ultimate fan experiences, beer, wings, whiskey, and more at SweetWater Brewing Co., Montauk Brewing Co., Breckenridge Brewery, Blue Point Brewing Co., 10 Barrel Brewing Co., Hop Valley Brewing Co., Terrapin Beer Co., and Atwater Brewery
Read More
TLRY vs. CGC: Which Cannabis Stock is the Better Investment Now?
Published: January 30, 2026 by: Zacks Investment Research
Sentiment: Positive
Tilray Brands' international revenue surge, beverage scale and strong cash position give it an edge over Canopy Growth as cannabis regulation and demand continue to evolve.
Read More
Tilray Has Already Done The Hard Part
Published: January 28, 2026 by: Seeking Alpha
Sentiment: Positive
Tilray is strategically positioned to benefit from U.S. cannabis reform, leveraging its diversified international and U.S. beverage operations. International medical cannabis, especially in Europe, drives TLRY's growth and margin stability, with Germany and Italy as key markets. Profitability hinges on sustained double-digit international growth, normalized interest and restructuring costs, and EBITDA consistently covering capital needs.
Read More
February 2026 Watchlist: Leading Canadian Cannabis Stocks
Published: January 27, 2026 by: MarijuanaStocks
Sentiment: Positive
The Canadian cannabis sector continues evolving as companies adapt to shifting consumer demand and global regulations. While volatility remains common, long-term opportunities still attract patient investors. Moreover, potential U.S. federal reform continues to influence sentiment across Canadian operators. Many Canadian companies maintain indirect exposure to the U.S. cannabis market through branding, distribution, and strategic investments. As a result, these stocks often move in step with U.S. multi-state operators during major policy headlines.
Read More
Tilray Brands' Bullish Beverage Strategy: What's Behind the Optimism?
Published: January 26, 2026 by: Zacks Investment Research
Sentiment: Positive
TLRY's Beverage unit faces near-term pressure, but Project 420 savings, brand resets and global expansion underpin its long-term bullish view.
Read More
How Tilray Brands Is Acting on Its Vast International Opportunity
Published: January 20, 2026 by: Zacks Investment Research
Sentiment: Positive
TLRY posts a standout international quarter as cannabis revenues jump 36% year over year, driving supply shifts and broader global expansion.
Read More
3 Canadian Marijuana Stocks For Investors In 2026
Published: January 16, 2026 by: MarijuanaStocks
Sentiment: Positive
The cannabis industry is set to reach new horizons in 2026. More companies are coming together to take the industry to a level yet to be seen. With bigger and better partnerships taking effect this year, consumer demand should go beyond mere satisfaction. Along with the political climate around cannabis in the US, marijuana stocks could see a jump from all of the above. 2026 brings in a large amount of positive speculation with all that is going on.
Read More
Weekly Jobless Claims Come in Muted
Published: January 08, 2026 by: Zacks Investment Research
Sentiment: Neutral
Weekly Jobless Claims Come in Muted.
Read More
Tilray Q2: High Hopes or Harsh Reality?
Published: January 06, 2026 by: Benzinga
Sentiment: Neutral
As Canadian cannabis king Tilray Brands, Inc. (NASDAQ: TLRY) prepares to report its fiscal Q2 2026 results on Thursday, the company stands at a crossroads.
Read More
Tilray Brands Readies for Q2 Earnings: Here's What You Should Know
Published: January 06, 2026 by: Zacks Investment Research
Sentiment: Positive
TLRY's faces margin pressure in cannabis and beverages, but management sees a beverage turnaround and wellness strength cushioning quarterly results.
Read More
How Long Will the Cannabis Stock Rally Last?
Published: January 01, 2026 by: The Motley Fool
Sentiment: Positive
Cannabis stocks have had significant momentum due to positive regulatory changes in the U.S. However, this momentum is likely to be relatively short-lived. These 10 Stocks Could Mint the Next Wave of Millionaires ›
Read More
Riding the Marijuana Reclassification Wave: 3 Stocks to Watch in 2026
Published: December 31, 2025 by: Zacks Investment Research
Sentiment: Positive
Marijuana's potential move to Schedule III could reshape cannabis economics, putting CRON, VFF and TLRY in focus for 2026 investors.
Read More
The 2026 Cannabis Wildcard: How Tax Reform Could Reset Stock Valuations
Published: December 30, 2025 by: MarketBeat
Sentiment: Neutral
On Dec. 18, 2025, President Trump signed a pivotal Executive Order directing the Attorney General to expedite the rescheduling of cannabis. By all traditional metrics, this political victory should have sparked a sustained rally.
Read More
3 Marijuana Stocks To Watch In 2026
Published: December 26, 2025 by: MarijuanaStocks
Sentiment: Positive
The cannabis industry is entering another critical growth phase, positioning 2026 as a potentially pivotal year. Particularly for long-term investors looking to make a profit with marijuana stocks. After years of regulatory uncertainty, capital constraints, and volatile price action, relief is being shown. The legal cannabis market is showing clear signs of structural improvement driven by policy reform, consolidation, and expanding global demand.
Read More
3 Top Marijuana Stocks After Cannabis Gets Rescheduled
Published: December 22, 2025 by: MarijuanaStocks
Sentiment: Positive
Donald Trump's recent executive order moving cannabis off Schedule I marks a pivotal moment for the U.S. cannabis sector. While the order does not legalize marijuana at the federal level, rescheduling fundamentally changes how the plant is viewed under federal law. With meaningful implications for operators, investors, and public markets. For the cannabis industry, the most immediate impact is financial. A shift to Schedule III would effectively eradicate IRS Section 280E. This is a law that currently prevents cannabis businesses from deducting standard operating expenses.
Read More
Tilray Brands to Announce Second Quarter Fiscal Year 2026 Financial Results on January 8, 2026
Published: December 22, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK and LEAMINGTON, Ontario, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage and wellness industries, today announced that the Company will release its financial results for the second fiscal quarter which ended November 30, 2025, after the financial markets close on Thursday, January 8, 2026.
Read More
3 Best Cannabis Stocks: Will They Fly High Again Post Trump Schedule III?
Published: December 19, 2025 by: Seeking Alpha
Sentiment: Neutral
Cannabis stocks sold off this week following President Trump's Executive Order directing marijuana's reclassification to Schedule III for increased medical and cannabidiol research. The sharp selloff highlights how fragile sentiment in cannabis stock remains, even amid policy progress. Further volatility is possible if regulatory implementation drags on or if broader market risk appetite weakens.
Read More
Trump signs executive order to reschedule cannabis. Here's what's next
Published: December 19, 2025 by: CNBC Television
Sentiment: Positive
Trump's executive order shifts cannabis from Schedule I to Schedule III, and launches a Medicare pilot program for CBD products. Brandon Gomez unpacks what's next, the hurdles ahead and what shifted the President's stance on the drug.
Read More
Trump just legalized marijuana nationwide — here's why potheads are rejoicing
Published: December 19, 2025 by: New York Post
Sentiment: Positive
As On The Money has been reporting since April, our famously drug-and-drink-averse president has been inching ever closer to making marijuana significantly less criminal in the eyes of the federal government.
Read More
Trump Orders Marijuana Reclassification: What It Means for the Sector
Published: December 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Trump's executive order to move marijuana to Schedule III could reshape cannabis regulation and taxes, lifting sentiment around cannabis stocks.
Read More
Trump sparks market shock with MAJOR marijuana move
Published: December 19, 2025 by: Fox Business
Sentiment: Negative
Rep. Greg Steube, R-Fla., joins ‘Mornings with Maria' to discuss cutting healthcare costs, the fight over Obamacare subsidies and shutdown risks, President Donald Trump's marijuana order and the GOP's push to sell unused federal buildings.
Read More
Trump signs executive order to reschedule marijuana, expand access to CBD products
Published: December 18, 2025 by: Proactive Investors
Sentiment: Positive
President Donald Trump on Thursday signed an executive order directing the federal government to move marijuana from Schedule I to Schedule III, potentially easing regulatory and financial constraints for cannabis companies while keeping recreational use illegal under federal law. The order instructs the attorney general to expedite the ongoing process of rescheduling marijuana, which is currently classified alongside heroin and LSD as a Schedule I drug — considered to have a high potential for abuse and no accepted medical use.
Read More
President Trump signs executive order to reclassify marijuana, easing federal restrictions
Published: December 18, 2025 by: CNBC Television
Sentiment: Positive
President Trump signs an executive order to reclassify marijuana to a Schedule III classification, easing federal restrictions.
Read More
TLRY Soars on Marijuana Reclassification Hopes, Burning Question Centers on Profits
Published: December 18, 2025 by: Schwab Network
Sentiment: Positive
Tilray Brands (TLRY) has been one of the top stocks gaining momentum in the cannabis space as President Trump is expected to sign an executive order reclassifying cannabis. George Tsilis says that paving a clean path for legalization does not equate to more demand, thus more revenue.
Read More
Trump Signs Order Easing Federal Restrictions on Marijuana
Published: December 18, 2025 by: Bloomberg Markets and Finance
Sentiment: Positive
President Donald Trump signs an executive order directing his administration to move cannabis into a less restrictive federal category. Sign up for the Washington Edition newsletter to find out how the worlds of money and politics intersect in the US capital: https://bloom.bg/3KkEimO -------- More on Bloomberg Television and Markets Like this video?
Read More
Tilray Accelerates U.S. Medical Cannabis Expansion After Landmark Federal Rescheduling: Launches Tilray Medical USA to Lead Nationwide Medical Cannabis Innovation and Growth
Published: December 18, 2025 by: GlobeNewsWire
Sentiment: Neutral
Global Cannabis Leader Poised for Major U.S. Market Entry, Signaling New Era for Healthcare Global Cannabis Leader Poised for Major U.S. Market Entry, Signaling New Era for Healthcare
Read More
Trump signs executive order easing federal restrictions on marijuana
Published: December 18, 2025 by: Business Insider
Sentiment: Positive
Trump signed an executive order that will reclassify marijuana as a less harmful drug. The order is aimed at making it easier to research the drug.
Read More
Trump signs executive order reclassifying pot, opening door to broader access
Published: December 18, 2025 by: CNBC
Sentiment: Positive
President Donald Trump signed an executive order Thursday reclassifying marijuana as a Schedule III substance with looser restrictions.
Read More
Trump moves to ease cannabis restrictions - what does it mean for consumers?
Published: December 18, 2025 by: Reuters
Sentiment: Positive
U.S. President Donald Trump said he will direct the U.S. Department of Justice to reclassify cannabis as a less dangerous drug. Here's a look at what that would mean for people shopping at dispensaries across the country.
Read More
About Tilray Brands, Inc. (TLRY)
- IPO Date 2018-07-19
- Website https://www.tilray.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Irwin David Simon
- Employees 2650